← Back to front page
Americas · General news · Toronto Star

Precede Biosciences Presents ESMO 2026 Data Revealing Biology Associated with Response and Resistance to PSMA-Directed Radioligand Therapy in Advanced Prostate Cancer

Published by Toronto Star · Canada 9 h ago

Baseline plasma profiling identified three molecular states previously characterized in tissue: androgen receptor (AR)-high/metabolic, stem/epithelial–mesenchymal transition…

Read the full article on Toronto Star Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.thestar.com)

Also worth reading